PTD unknown

ovarian cancer breakthrough

  1. bobbuck
    286 Posts.
    clock Created with Sketch.
    22/06/05
    10:28
    Post #: 956662
    In a study conducted at the Ovarian Cancer Research Foundation (OCRF) at Monash
    Medical Centre in Melbourne, an antibody detection method developed by Biosceptre
    successfully identified 100% of the invasive ovarian carcinomas (malignant cancers of
    the ovaries) included in the tissue analysis.
    PTD Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Win a $12k Portfolio | 7%-10.25% low risk rental yield from a proven asset
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 32
right-arrow Created with Sketch.
NEWS RBA's inflation trick: Is the number lying to us?
right-arrow Created with Sketch.
NEWS Expert Exchange: Laretive's 4 key strategies to picking ASX winners
right-arrow Created with Sketch.
NEWS Lithium hype is back. Just ignore the fact Jianxiawo only supplies 3% globally
right-arrow Created with Sketch.
NEWS Iress Ltd leads top gainers intraday Friday as Blackstone buyout bid confirmed
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.